home

US Market news

headline news | recent news | latest news | market news | recent topics | stock topics

Global news - chevrons indicate local prediction, arrows show global predictions, circles show importance

CFB US
CrossFirst Bankshares, Inc. To HostFirst Quarter 2024 Earnings Call
CrossFirst Bankshares, Inc. To Host First Quarter 2024 Earnings Call - globenewswire
25m ago
link
WBA US
Why Walgreens Boots Alliance Stock Trounced the Market Today
The company notches convincing beats on headline fundamentals in its second-quarter earnings report. - fool
50m ago
link
RMD US
$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
ResMed (NYSE: RMD ) has outperformed the market over the past 10 years by 5.16% on an annualized basis producing an average annual return of 15.88%. Currently, ResMed has a market capitalization of $29.13 billion. Buying $1000 In RMD: If an ... Full story available on Benzinga.com - benzinga
1h ago
link
TRV US
Here's How Much You Would Have Made Owning Travelers Companies Stock In The Last 20 Years
Travelers Companies (NYSE: TRV ) has outperformed the market over the past 20 years by 1.08% on an annualized basis producing an average annual return of 8.96%. Currently, Travelers Companies has a market capitalization of $52.73 billion. Buying $100 In TRV: If ... Full story available on Benzinga.com - benzinga
1h ago
link
PXS US
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, reported today that Pyxis Oncologys Compensation Committee of the Board of Directors granted restricted stock units with respect to an aggregate of 39,680 shares of Pyxis Oncologys common stock and stock options to purchase an aggregate of 49,600 shares of Pyxis Oncologys common stock to a newly hired employee. The awards were granted under the Pyxis Oncology, Inc. 2022 Inducement Plan with a grant date of March 28, 2024, as an inducement material to the new employee entering employment with Pyxis Oncology, in accordance with Nasdaq Listing Rule 5635(c)(4). - globenewswire
1h ago
link
GME US
GameStop Stock Downtrend Is Intact: The End Game Draws Near
Shares of GameStop (NYSE: GME ) have been trending lower ever since the meme stock frenzy first spiked, and the downtrend is intact. The company continues to bleed business and cash, putting it in a downward spiral, and investors should flee. The stock is still tradable, but bullish traders beware; one day's gains will likely turn into losses tomorrow, next week, and next year.  As appealing as the business model is, it relies on a niche, after-market business that has yet to produce sustainable growth or profitability and probably never will. If you are wondering what the end-game for this stock is, the most likely scenario is to revert to the pre-meme price points below $5.  No Game In GameStop Q4 Results GameStop had a weak quarter in Q4, missing the Marketbeat.com consensus estimates on the top and bottom lines. The company brought in $1.79 billion in net revenue for a decline of 19.7% YOY that missed the consensus by 1200 basis points as clients cut back on har - benzinga
1h ago
link
AFL US
Aflac Incorporated to Release First Quarter Results and CFO Video Update on May 1, 2024 and Host Webcast on May 2, 2024
COLUMBUS, Ga., March 28, 2024 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will release first quarter 2024 financial results after the market closes on May 1, 2024. At that time, earnings materials, including the quarterly earnings release and financial... - prnewswire:443
1h ago
link
AHH US
Armada Hoffler to Discuss First Quarter Earnings on May 9th
VIRGINIA BEACH, Va., March 28, 2024 (GLOBE NEWSWIRE) -- Armada Hoffler (NYSE: AHH ) will report its earnings for the quarter ending March 31, 2024 at approximately 6:00 a.m. Eastern on Thursday, May 9, 2024. At 8:30 a.m. Eastern on the same day, senior management will host a conference call and webcast to discuss earnings and other information. To listen to the call, dial (+1) 888-259-6580 (toll-free dial-in number) or (+1) 416-764-8624 (toll dial-in number). The conference ID is 56300446. The conference call ... Full story available on Benzinga.com - benzinga
1h ago
link
FSLY US
Where Fastly Stands With Analysts
During the last three months, 4 analysts shared their evaluations of Fastly (NYSE: FSLY ), revealing diverse outlooks from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 3 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 1 0 0 3M Ago 0 0 2 0 0 In the assessment of 12-month price targets, analysts unveil insights for Fastly, presenting an average target of $19.0, a high estimate of $20.00, and a low estimate of $18.00. Observing a 11.76% increase, the current average has risen from the previous average price target of $17.00. Exploring Analyst Ratings: An In-Depth Overview The analysis of recent analyst actions sheds light on the - benzinga
1h ago
link
OZK US
Bank OZK Announces Date for First Quarter 2024 Earnings Release and Conference Call
LITTLE ROCK, Ark., March 28, 2024 (GLOBE NEWSWIRE) -- Bank OZK (the Bank) (Nasdaq: OZK) expects to report its first quarter 2024 earnings after the market closes on Wednesday, April 17, 2024. Managements comments on the first quarter of 2024 will be released simultaneously with the earnings press release and will be available on the Banks investor relations website. - globenewswire
1h ago
link
EQIX US
Expert Outlook: Equinix Through The Eyes Of 12 Analysts
In the preceding three months, 12 analysts have released ratings for Equinix (NASDAQ: EQIX ), presenting a wide array of perspectives from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 3 6 0 0 Last 30D 0 0 1 0 0 1M Ago 2 2 2 0 0 2M Ago 0 1 2 0 0 3M Ago 1 0 1 0 0 In the assessment of 12-month price targets, analysts unveil insights for Equinix, presenting an average target of $816.42, a high estimate of $960.00, and a low estimate of $91.00. Surpassing the previous average price target of $758.00, the current average has increased by 7.71%. Analyzing Analyst Ratings: A Detailed Breakdown An in-depth analysis of recent analyst actions unveils how - benzinga
1h ago
link
VEEV US
$1000 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today
Veeva Systems (NYSE: VEEV ) has outperformed the market over the past 10 years by 13.57% on an annualized basis producing an average annual return of 24.32%. Currently, Veeva Systems has a market capitalization of $37.65 billion. Buying $1000 In VEEV: If ... Full story available on Benzinga.com - benzinga
2h ago
link
TAP US
MOLSON COORS OFFERS WORKERS 5 CENTS, CONTRACT NEGOTIATIONS COLLAPSE IN TEXAS
41-Day Strike Continues, Teamsters Boycott Coors and Miller During March Madness FORT WORTH, Texas, March 28, 2024 /PRNewswire/ -- Negotiations with Molson Coors broke off on Thursday over the multibillion-dollar beermaker's refusal to agree to real wage increases for Teamsters in a new... - prnewswire:443
2h ago
link
AAPL US
Pixalates March 2024 Ad Fraud Research on CTV Apps with the Highest Invalid Traffic (IVT) Rate on Roku, Amazon Fire TV, Apple TV, Samsung Smart TV App Stores: 17% Global IVT Rate
Research finds a 17% invalid traffic (IVT, including ad fraud) rate across global Connected TV (CTV) open programmatic ad traffic from March 1-17, 2024; Xumo Play (23%) had the highest IVT rate among Samsung Smart TV apps in the time period, while Food Network GO (46%) had the highest among Amazon Fire TV apps Research finds a 17% invalid traffic (IVT, including ad fraud) rate across global Connected TV (CTV) open programmatic ad traffic from March 1-17, 2024; Xumo Play (23%) had the highest IVT rate among Samsung Smart TV apps in the time period, while Food Network GO (46%) had the highest among Amazon Fire TV apps - globenewswire
2h ago
link
DVN US
What Analysts Are Saying About Devon Energy Stock
Ratings for Devon Energy (NYSE: DVN ) were provided by 8 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 3 1 0 0 Last 30D 0 1 0 0 0 1M Ago 2 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 2 2 0 0 0 Analysts have recently evaluated Devon Energy and provided 12-month price targets. The average target is $57.88, accompanied by a high estimate of $75.00 and a low estimate of $49.00. A decline of 3.53% from the prior average price target is evident in the current average. Analyzing Analyst Ratings: A Detailed Breakdown An in-depth analysis of recent analyst actions unveils how fin - benzinga
2h ago
link
SIBN US
Peeling Back The Layers: Exploring SI-BONE Through Analyst Insights
In the last three months, 4 analysts have published ratings on SI-BONE (NASDAQ: SIBN ), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 0 1 0 0 0 1M Ago 1 2 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $25.0, a high estimate of $26.00, and a low estimate of $24.00. A decline of 1.3% from the prior average price target is evident in the current average. Diving into Analyst Ratings: An In-Depth Exploration A comprehensive examination of how financial experts perce - benzinga
2h ago
link
KLAC US
Here's How Much You Would Have Made Owning KLA Stock In The Last 20 Years
KLA (NASDAQ: KLAC ) has outperformed the market over the past 20 years by 5.86% on an annualized basis producing an average annual return of 13.73%. Currently, KLA has a market capitalization of $93.95 billion. Buying $100 In KLAC: If an ... Full story available on Benzinga.com - benzinga
2h ago
link
INTU US
Here's How Much You Would Have Made Owning Intuit Stock In The Last 10 Years
Intuit (NASDAQ: INTU ) has outperformed the market over the past 10 years by 12.7% on an annualized basis producing an average annual return of 23.43%. Currently, Intuit has a market capitalization of $181.40 billion. Buying $1000 In INTU: If an ... Full story available on Benzinga.com - benzinga
2h ago
link
MSM US
Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 Results
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 15 points on Thursday. The Dow traded up 0.06% to 39,785.29 while the NASDAQ fell 0.13% to 16,383.85. The S&P 500 also rose, gaining, 0.10% to 5,253.70. Check This Out: Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'   Leading and Lagging Sectors   Energy shares jumped by 1.1% on Thursday. In trading on Thursday, communication services shares fell by 0.2%.   Top Headline   Shares of MSC Industrial Direct Co., Inc. (NYSE: MSM ) fell over 2% during Thursday’s session after the company reported mixed second-quarter results. MSC Industrial Direct reported second-quarter FY24 net sales decline of 2.7% Y/Y to $935.3 million, missing the consensus of $946.5 million. Adjusted EPS of $1.18, down 18.6%, beating the consensus of $1.16. MSC Industrial reiterated the outlook for FY24 ADS gro - benzinga
2h ago
link
LLY US
Eli Lilly climbs on win for rival weight-loss drug, and we still feel good about Abbott Labs
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading. - cnbc
2h ago
link
KMB US
Kimberly-Clark's Long Term Outlook, Cost Savings Plan Looks Encouraging, Analyst Says
Piper Sandler  analyst Korinne Wolfmeyer reiterated an  Overweight rating  on the shares of  Kimberly-Clark Corp  (NYSE: KMB ) and raised the price target from $145 to $152. KMB is entering a new operating model focused on accelerating innovation across powerhouse brands, optimizing the cost structure, and re-organizing operations  into three new business segments. According to the analyst, about $200 million of selling, general and administrative savings should be realized over the next 2 years which should be reinvested back into the business. Come of the strategies the company is planning ... Full story available on Benzinga.com - benzinga
3h ago
link
BKE US
Buttoning Up Rich Call Premium And Dividend With Buckle Call Write
On the buy write, if we earn the dividend, and if BKE closes above $42.50 on May 17, you would earn $3.55 per share on $39.30 per share at risk, or 9.03%. Over a 50-day holding period, that would be an annualized return of 65.9%. - forbes
3h ago
link
INVH US
Critical Insights From Invitation Homes Analyst Ratings: What You Need To Know
Ratings for Invitation Homes (NYSE: INVH ) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 5 4 0 0 Last 30D 0 1 0 0 0 1M Ago 0 1 4 0 0 2M Ago 0 1 0 0 0 3M Ago 1 2 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $38.3, a high estimate of $41.00, and a low estimate of $36.00. Marking an increase of 7.89%, the current average surpasses the previous average price target of $35.50. Exploring Analyst Ratings: An In-Depth Overview The perception of Invitation Homes by financial experts is analyzed through - benzinga
3h ago
link
ABT US
How Is The Market Feeling About Abbott Laboratories?
Abbott Laboratories's (NYSE: ABT ) short percent of float has risen 12.16% since its last report. The company recently reported that it has 14.29 million shares sold short , which is 0.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.7 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price ... Full story available on Benzinga.com - benzinga
3h ago
link
WDAY US
How Is The Market Feeling About Workday?
Workday's (NYSE: WDAY ) short percent of float has fallen 8.72% since its last report. The company recently reported that it has 2.83 million shares sold short , which is 1.36% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.52 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price ... Full story available on Benzinga.com - benzinga
3h ago
link
REGN US
Behind the Scenes of Regeneron Pharmaceuticals's Latest Options Trends
Deep-pocketed investors have adopted a bullish approach towards Regeneron Pharmaceuticals (NASDAQ: REGN ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in REGN usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Regeneron Pharmaceuticals. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 3 are puts, totaling $182,250, and 5 are calls, amounting to $358,256. Predicted Price Range Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $930.0 to $1260.0 for Regenero - benzinga
3h ago
link
ANET US
Here's How Much You Would Have Made Owning Arista Networks Stock In The Last 5 Years
Arista Networks (NYSE: ANET ) has outperformed the market over the past 5 years by 16.68% on an annualized basis producing an average annual return of 29.53%. Currently, Arista Networks has a market capitalization of $89.61 billion. Buying $100 In ANET: If ... Full story available on Benzinga.com - benzinga
4h ago
link
ZTS US
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
Zoetis (NYSE: ZTS ) has outperformed the market over the past 10 years by 8.44% on an annualized basis producing an average annual return of 19.17%. Currently, Zoetis has a market capitalization of $78.33 billion. Buying $1000 In ZTS: If an ... Full story available on Benzinga.com - benzinga
4h ago
link
CHT US
P/E Ratio Insights for Chunghwa Telecom
In the current market session, Chunghwa Telecom Inc. (NYSE: CHT ) share price is at $39.16, after a 0.43% drop. Over the past month, the stock went up by 3.18% , but over the past year, it actually decreased by 0.28% . With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. Comparing Chunghwa Telecom P/E Against Its Peers The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, ... Full story available on Benzinga.com - benzinga
4h ago
link
GTH US
Genetron Health Announces Completion of Going Private Transaction
BEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (('Genetron Health' or the 'Company', NASDAQ: GTH ), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced today the completion of its merger (the 'Merger') with Genetron New Co Limited ('Merger Sub'), pursuant to the previously announced agreement and plan of merger, dated as of October 11, 2023 (the 'Merger Agreement'), among the Company, New Genetron Holding Limited ('Parent') and Merger Sub. As a result of the Merger, the Company has become a wholly owned subsidiary of Parent and will cease to be a publicly traded company. Pursuant to the terms of the Merger Agreement, which was approved by the Company's shareholders at an extraordinary general meeting held on February 21, 2024, each ordinary share, par value US$0.00002 per share, of the Company (each, a 'Share') iss - benzinga
4h ago
link
MSM US
MSC Industrial's Rocky Q2 Earnings Hint At A Cautious FY24 Outlook: Details
MSC Industrial Direct Co., Inc.  (NYSE: MSM )   shares are trading lower after the reported second-quarter FY24 net sales decline of 2.7% Y/Y to $935.3 million,  missing the consensus of $946.5 million . Average daily sales fell 2.7% Y/Y on continued softness in heavy manufacturing verticals. Adjusted operating income declined 16.5% to $97.8 million, with the operating margin compressing to 10.5% from 12.2% a year ago. Adjusted EPS of $1.18, down 18.6%, beating  the consensus of $1.16 . As of March 2, 2024, the company held ... Full story available on Benzinga.com - benzinga
4h ago
link
TNXP US
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP ) shares are trading lower by 33.9% to $0.22 Thursday afternoon after the company announced the pricing of a $4.4 million registered direct offering . Tonix has initiated a securities purchase agreement with existing healthcare-focused institutional investors for the sale of 14,666,666 shares of its common stock and accompanying warrants in a registered direct offering at a combined price of $0.30 per share. The offering, expected to close around April 1, 2024, is anticipated to generate gross proceeds of approximately $4.4 million. The net proceeds will be allocated towards working capital, general corporate purposes, and partial repayment of debt. A.G.P./Alliance Global Partners is the sole placement agent for the offering. In addition to the offering, the company has agreed to amend certain existing warrants issued in 2023, reducing their exercise price ... Full story available on Benzinga.com - benzinga
4h ago
link
PPC US
Supplementary Review: Pilgrims Pride (PPC), March 28, 2024
Shares of PPC have fared well since out last review on February 26, rising about 12% compared to just a 4% gain in the S&P 500 and actually surpassing our current [...] - forbes
4h ago
link
MDB US
Decoding 26 Analyst Evaluations For MongoDB
In the latest quarter, 26 analysts provided ratings for MongoDB (NASDAQ: MDB ), showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 11 9 4 0 2 Last 30D 1 0 0 0 0 1M Ago 8 7 2 0 2 2M Ago 1 1 0 0 0 3M Ago 1 1 2 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $447.46, a high estimate of $550.00, and a low estimate of $272.00. Highlighting a 4.26% decrease, the current average has fallen from the previous average price target of $467.37. Diving into Analyst Ratings: An In-Depth Exploration A comprehensive examination of how financial experts - benzinga
4h ago
link
FC US
Analyst Ratings For Franklin Covey
In the latest quarter, 4 analysts provided ratings for Franklin Covey (NYSE: FC ), showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 4 0 0 0 Last 30D 0 2 0 0 0 1M Ago 0 1 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 1 0 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $62.5, with a high estimate of $95.00 and a low estimate of $45.00. This current average represents a 19.35% decrease from the previous average price target of $77.50. Exploring Analyst Ratings: An In-Depth Overview An in-depth analysis of recent analyst actions unveils how financial expe - benzinga
4h ago
link
PEP US
This Is What Whales Are Betting On PepsiCo
Whales with a lot of money to spend have taken a noticeably bearish stance on PepsiCo . Looking at options history for PepsiCo (NASDAQ: PEP ) we detected 9 trades. If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 55% with bearish. From the overall spotted trades, 4 are puts, for a total amount of $140,517 and 5, calls, for a total amount of $247,215. Predicted Price Range After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $170.0 and $200.0 for PepsiCo, spanning the last three months. Volume & Open Interest Trends In terms of liquidity and interest, the mean open interest for PepsiCo options trades today is 787.29 with a total volume of 1,201.00. In the following chart, we are able ... Full story available on Benzinga.com - benzinga
4h ago
link
CFR US
Cullen/Frost Bankers Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
In the latest quarter, 9 analysts provided ratings for Cullen/Frost Bankers (NYSE: CFR ), showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 6 2 0 Last 30D 1 0 0 1 0 1M Ago 0 0 0 0 0 2M Ago 0 0 2 0 0 3M Ago 0 0 4 1 0 Analysts have recently evaluated Cullen/Frost Bankers and provided 12-month price targets. The average target is $116.56, accompanied by a high estimate of $126.00 and a low estimate of $111.00. Witnessing a positive shift, the current average has risen by 2.89% from the previous average price target of $113.29. Exploring Analyst Ratings: An In-Depth Overview A comprehensive examination - benzinga
4h ago
link
AA US
Alcoa's Options: A Look at What the Big Money is Thinking
Deep-pocketed investors have adopted a bullish approach towards Alcoa (NYSE: AA ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AA usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Alcoa. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 4 are puts, totaling $196,359, and 4 are calls, amounting to $357,983. Expected Price Movements After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $25.0 and $40.0 for Alcoa, spanning the last three mont - benzinga
4h ago
link
MU US
$1000 Invested In Micron Technology 15 Years Ago Would Be Worth This Much Today
Micron Technology (NASDAQ: MU ) has outperformed the market over the past 15 years by 11.39% on an annualized basis producing an average annual return of 24.34%. Currently, Micron Technology has a market capitalization of $132.29 billion. Buying $1000 In MU: If ... Full story available on Benzinga.com - benzinga
4h ago
link
KTCC US
Silent Quadrant Elevates Tronic's Market Value with Security-First Approach
Strategic Partnership Between Silent Quadrant and JBB Advanced Technologies Maximizes Subsidiary Value, showcasing JBBAT's commitment to innovation and security. DALLAS, March 28, 2024 /PRNewswire/ -- Silent Quadrant, a premier cybersecurity consultancy, through its strategic partnership... - prnewswire:443
4h ago
link
DKS US
DEADLINE ALERT for INMD, AMPL, NOVA, DKS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
BENSALEM, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. - globenewswire
4h ago
link
MET US
How Is The Market Feeling About MetLife?
MetLife's (NYSE: MET ) short percent of float has fallen 11.36% since its last report. The company recently reported that it has 7.01 million shares sold short , which is 1.17% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.42 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price ... Full story available on Benzinga.com - benzinga
5h ago
link
MO US
(MO) - Analyzing Altria Group's Short Interest
Altria Group's (NYSE: MO ) short percent of float has fallen 10.75% since its last report. The company recently reported that it has 14.61 million shares sold short , which is 0.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.45 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price ... Full story available on Benzinga.com - benzinga
5h ago
link
CTAS US
Cintas Analysts Increase Their Forecasts After Upbeat Earnings
Cintas Corporation (NASDAQ: CTAS ) reported better-than-expected third-quarter financial results and raised FY24 guidance . Cintas posted GAAP earnings of $3.84 per share, beating market estimates of $3.59 per share. The company’s quarterly sales came in at $2.406 billion, versus expectations of $2.386 billion, according to data from Benzinga Pro. Todd M. Schneider, Cintas’ President, and Chief Executive Officer, stated, “Each of our operating segments continue to execute at a high level, which led to robust revenue growth of 9.9%, record high gross margin of 49.4%, record high operating margin of 21.6% and diluted EPS growth of 22.3%.” Cintas increased FY24 annual ... Full story available on Benzinga.com - benzinga
5h ago
link
INOD US
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Innodata Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action INOD
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Innodata Inc. (NASDAQ: INOD) between May 9, 2019 and February 14, 2024, both dates inclusive (the Class Period), of the important April 22, 2024 lead plaintiff deadline. - globenewswire
5h ago
link
RDFN US
Why Redfin Stock Was Climbing Today
More signs of a strengthening housing market appeared. - fool
5h ago
link
LUNA US
Luna Innovations (LUNA) Falls Again After CEO Abruptly Leaves Following LUNA's Admission of Improper Revenue Recognition, Pending Restatements -- Hagens Berman
SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Luna Innovations Incorporated (NASDAQ: LUNA ) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/LUNA Contact An Attorney Now: LUNA@hbsslaw.com 844-916-0895 Luna Innovations Incorporated (LUNA) Investigation: On Mar. 25, 2024, Luna announced that its CEO Scott Graeff has retired from his role as President and Chief Executive Officer of the Company and has stepped down from the Board of Directors, sending the price of fiber optic test and control company Luna Innovations shares sharply lower during intraday trading. Luna announced that its Board has initiated a search for a new President and CEO, and that longtime Chairman Richard Roedel has been appointed Executive Chairman and President on an ... Full story available on Benzinga.com - benzinga
5h ago
link
DIS US
Disney steeling for activist-investor showdown on April 3
- marketwatch
5h ago
link
TSLA US
Tesla has had a nightmare first quarter amid weak China demand
Wedbushs Dan Ives trims his stock-price target for Tesla to $300 from $315 after a perfect storm of issues. - marketwatch
5h ago
link
AMGN US
Amgen Options Trading: A Deep Dive into Market Sentiment
Deep-pocketed investors have adopted a bullish approach towards Amgen (NASDAQ: AMGN ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMGN usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Amgen. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 77% leaning bullish and 22% bearish. Among these notable options, 3 are puts, totaling $302,209, and 6 are calls, amounting to $191,492. Projected Price Targets After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $240.0 and $320.0 for Amgen, spanning the ... Fu - benzinga
5h ago
link